Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,027,514
+$1,591,572 QoQ
Shares Held
143,430
+46.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $117,796,291 across 17 Drug Manufacturers - General names. PFE ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
228,025 | $49,593,157 | |
| 2 | LLY |
ELI LILLY & Co
|
27,501 | $25,294,594 | |
| 3 | JNJ |
Johnson & Johnson
|
79,700 | $19,481,868 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,030 | $4,815,208 | |
| 5 | PFE |
Pfizer Inc
This page
|
143,430 | $4,027,514 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,884 | $3,328,713 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,185 | $3,165,020 | |
| 8 | AMGN |
Amgen Inc
|
8,658 | $3,046,317 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,027,514 | 143,430 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,435,942 | 97,829 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,979,617 | 77,693 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,613,874 | 66,579 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,681,232 | 66,347 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,663,218 | 62,692 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,113,575 | 73,033 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,050,570 | 73,287 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,777,970 | 64,071 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $1,638,841 | 56,924 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,030,534 | 61,216 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,116,766 | 57,709 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,336,167 | 57,259 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,718,486 | 53,054 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $2,159,774 | 49,355 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,587,682 | 49,355 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,750,253 | 46,575 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $5,236,983 | 121,762 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,041,575 | 128,743 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,535,380 | 125,183 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||